AMERICAN buyers were reported to be all over ReNeuron ; MARKET REPORT [Edition 3]
Linked as:
Summary
AMERICAN buyers were reported to be all over ReNeuron, 1.1p up at 65/8 p, like a rash.
They helped to swell turnover in the stock to almost 8m shares amid intense speculation that the stem cell specialist company has been given the green light by the British Gene Therapy Advisory Committee to begin human trials of its ReN001 stem cell therapy for stroke victims.See the full content of this document
Extract
AMERICAN buyers were reported to be all over ReNeuron ; MARKET REPORT [Edition 3]
Read ...
See the full content of this document
Sponsored links
